HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Irvine-based Biolase Inc.’s shares soared today after it said it was unaware of any fundamental reason for the recent decline in its stock price.
Irvine-based healthcare software maker Quality Systems Inc. said today that Chief Executive Steven Plochocki will retire effective June 30.
Irvine-based JenaValve Technology Inc. said today that Victoria Carr-Brendel is the company’s new chief executive.
Douglas Ingram, former president of drug maker Allergan Inc., has joined the board of Costa Mesa-based startup Nemus Bioscience Inc. in the newly created role of vice chairman.
MicroVention Inc., a Tustin-based developer, manufacturer and marketer of neuroendovascular technologies, said it will be building a large new office in Aliso Viejo for its new headquarters.
Children’s Hospital of Orange County said today it's building a new children’s mental health inpatient center as part of an initiative that will be supported by a $5 million gift from Sandy Segerstrom Daniels.
Irvine-based Edwards Lifesciences Corp. said today that it is voluntarily halting enrollment in an early clinical trial for an experimental, less-invasive mitral heart valve.
Irvine-based Biolase Inc. said today that Harold Flynn Jr. will become its new chief executive, effective July 13.
Irvine-based Masimo Corp. said today that a federal court in Delaware has upheld a $467 million jury verdict in its favor against a pair of Netherlands-based Royal Philips Electronics NV's units for patent infringement.
Laguna Hills-based Glaukos Corp. has filed plans to raise $86 million in an initial public offering.
Irvine-based HCP Inc. has acquired a building in Philadelphia for $161 million, according to a federal filing.
Irvine-based Alphaeon Corp. said today that it named former Securities and Exchange Commissioner Christopher Cox and Silicon Valley executive Dennis Wolf to its board of directors.
Mission Viejo-based Ensign Group Inc. said today it bought one skilled nursing facility in Washington and a subsidiary bought two skilled nursing facilities in Utah, on undisclosed terms.
University of California-Irvine said it will get up to $5 million over five years from the federal National Institute of Allergy & Infectious Diseases to further develop a bloodstream infection-detection system that speeds diagnosis times and improves accuracy.
Matthew Maletta, a former associate general counsel with Irvine-based Allergan Inc., was named chief legal officer of Endo International plc.